Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Uterine Corpus Cancer
11
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00063999
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Completed · Phase 3
NCT00575952
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer
Completed · Phase 1
NCT00942357
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Unknown · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Uterine Corpus Cancer
🏥 Names
Disease Name
Uterine Corpus Cancer
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
🔗 External References
HERB DB
DisGeNET
C1883486
🔍 Raw view — every non-empty column on this row (19 fields)
name
Uterine Corpus Cancer
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
umls disease type id
T191
herb disease id
HBDIS018548
disgenet id
C1883486
⚗️ Related Ingredients
1 · shared evidence📋 Clinical Trials
11 · subject of clinical studyNCT00063999 Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitax
→ Recurrent Uterine Corpus Carcinoma|Stage IIIA Uter
NCT00575952 Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating
→ Endometrial Adenosquamous Carcinoma|Endometrial Cl
NCT00942357 Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Tr
→ Endometrial Clear Cell Adenocarcinoma|Endometrial
NCT00977574 Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsiro
→ Endometrial Adenocarcinoma|Endometrial Adenosquamo
NCT01005329 Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Ca
→ Endometrial Adenocarcinoma|Endometrial Adenosquamo
NCT01440998 Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or
→ Endometrial Adenocarcinoma|Endometrial Clear Cell
NCT02065687 Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating P
→ Endometrial Adenocarcinoma|Endometrial Clear Cell
NCT02501954 Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Thera
→ Endometrial Clear Cell Adenocarcinoma|Endometrial
NCT02684227 Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV
→ Recurrent Endometrial Endometrioid Adenocarcinoma|
NCT00005840 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage
→ Endometrial Clear Cell Adenocarcinoma|Endometrial
NCT00006011 Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Tr
→ Endometrial Adenocarcinoma|Endometrial Adenosquamo
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
empty — needs
HERB_herb_ingredientimport - Ingredient ↔ Target:
empty — needs
HERB_ingredient_targetimport - Target ↔ Disease:
empty — needs
HERB_target_diseaseimport - Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables